Intuitive Surgical, Inc. $ISRG Shares Sold by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 98,413 shares of the medical equipment provider’s stock after selling 8,616 shares during the period. Daiwa Securities Group Inc.’s holdings in Intuitive Surgical were worth $55,737,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Verus Capital Partners LLC increased its position in shares of Intuitive Surgical by 19.6% during the fourth quarter. Verus Capital Partners LLC now owns 1,109 shares of the medical equipment provider’s stock valued at $628,000 after acquiring an additional 182 shares during the last quarter. Cibc World Market Inc. increased its stake in Intuitive Surgical by 39.5% during the 4th quarter. Cibc World Market Inc. now owns 83,861 shares of the medical equipment provider’s stock worth $47,496,000 after buying an additional 23,741 shares during the period. Intellectus Partners LLC increased its stake in Intuitive Surgical by 33.9% during the 4th quarter. Intellectus Partners LLC now owns 8,108 shares of the medical equipment provider’s stock worth $4,592,000 after buying an additional 2,053 shares during the period. Sivia Capital Partners LLC lifted its holdings in Intuitive Surgical by 43.6% during the 4th quarter. Sivia Capital Partners LLC now owns 1,175 shares of the medical equipment provider’s stock worth $665,000 after buying an additional 357 shares in the last quarter. Finally, Bowen Hanes & Co. Inc. boosted its position in Intuitive Surgical by 2.7% in the 4th quarter. Bowen Hanes & Co. Inc. now owns 179,190 shares of the medical equipment provider’s stock valued at $101,486,000 after buying an additional 4,680 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG stock opened at $418.82 on Friday. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The stock has a market capitalization of $148.33 billion, a PE ratio of 50.77, a price-to-earnings-growth ratio of 3.25 and a beta of 1.46. The company has a fifty day moving average of $448.20 and a 200-day moving average of $501.58.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the business earned $1.81 EPS. The business’s revenue was up 23.0% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president directly owned 6,120 shares in the company, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 7,448 shares of company stock worth $3,224,404. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on ISRG shares. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Mizuho set a $525.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a report on Monday, April 13th. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research note on Wednesday, March 11th. HSBC cut their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, BTIG Research reaffirmed a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $573.63.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent commentary highlighted Intuitive Surgical’s AI-driven digital roadmap and the long-term growth potential of its da Vinci ecosystem, which could support future revenue from surgical data, software, and robotics adoption.
• Neutral Sentiment: Intuitive Surgical promoted Taylor Patton to Chief Commercial and Marketing Officer, signaling a sharper focus on global growth and commercial execution, but this is more of a strategic leadership update than an immediate earnings catalyst. Article Title
• Neutral Sentiment: Analysts remain divided overall: some firms maintain bullish ratings and high price targets, while others have trimmed targets or kept a cautious stance, reflecting uncertainty about how much growth is already priced into the stock.
• Negative Sentiment: Medtronic is seeking clearance for more indications for its Hugo surgical robot, which could intensify competition in major robotic surgery markets and challenge Intuitive Surgical’s leadership position. Article Title
• Negative Sentiment: Investor concern remains elevated after multiple pieces noted that ISRG has fallen sharply in 2026, with commentary questioning whether the recent weakness reflects a broader rerating after a strong prior run.
• Negative Sentiment: SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 transaction, which may still weigh on sentiment because insider selling can be read as a lack of near-term confidence. Article Title

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.